VNDA financials
Vanda Pharmaceuticals (VNDA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- VNDA revenue was $216.10M in fiscal 2025, net income -$220.47M.
VNDA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $216.10M | $203.06M | -$151.17M | -$220.47M | -3.74 |
| 2024 | $198.77M | $187.46M | -$40.66M | -$18.90M | -0.33 |
| 2023 | $192.64M | $177.84M | -$13.95M | $2.51M | 0.04 |
| 2022 | $254.38M | $230.10M | $6.33M | $6.28M | 0.11 |
| 2021 | $268.68M | $243.05M | $42.16M | $33.15M | 0.58 |
| 2020 | $248.17M | $224.80M | $27.24M | $23.34M | 0.42 |